418 related articles for article (PubMed ID: 24074049)
1. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
[TBL] [Abstract][Full Text] [Related]
2. [The application of the autologous serum eye drops results in significant improvement of the conjunctival status in patients with the dry eye syndrome].
Jirsová K; Hrdlicková E; Alfakih A; Juklová K; Filipec M; Faltus V; Veselá V
Cesk Slov Oftalmol; 2008 Mar; 64(2):52-6. PubMed ID: 18419102
[TBL] [Abstract][Full Text] [Related]
3. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye.
Versura P; Profazio V; Buzzi M; Stancari A; Arpinati M; Malavolta N; Campos EC
Cornea; 2013 Apr; 32(4):412-8. PubMed ID: 22955120
[TBL] [Abstract][Full Text] [Related]
5. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
6. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
Demiryay E; Yaylali V; Cetin EN; Yildirim C
Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
[TBL] [Abstract][Full Text] [Related]
7. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic dry eye treatment with autologous platelet-rich plasma.
Alio JL; Colecha JR; Pastor S; Rodriguez A; Artola A
Ophthalmic Res; 2007; 39(3):124-9. PubMed ID: 17374962
[TBL] [Abstract][Full Text] [Related]
10. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
11. The treatment of severe trachomatous dry eye with canalicular silicone plugs.
Guzey M; Ozardali I; Kilic A; Basar E; Dogan Z; Satici A; Karadede S
Eye (Lond); 2001 Jun; 15(Pt 3):297-303. PubMed ID: 11450724
[TBL] [Abstract][Full Text] [Related]
12. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
13. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
14. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis of conjunctival epithelial cells before and after the application of autologous serum eye drops in severe dry eye disease.
Rybickova I; Vesela V; Fales I; Skalicka P; Jirsova K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):271-5. PubMed ID: 26927466
[TBL] [Abstract][Full Text] [Related]
16. Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
Rao SN
J Ocul Pharmacol Ther; 2011 Dec; 27(6):603-9. PubMed ID: 21999340
[TBL] [Abstract][Full Text] [Related]
17. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
18. Effects of Autologous Serum Eye Drops on Conjunctival Expression of MUC5AC in Patients With Ocular Surface Disorders.
López-García JS; García-Lozano I; Rivas L; Giménez C; Acera A; Suárez-Cortés T
Cornea; 2016 Mar; 35(3):336-41. PubMed ID: 26785302
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease.
Simsek C; Dogru M; Shinzawa M; Den S; Kojima T; Iseda H; Suzuki M; Shibasaki Y; Yoshida N; Shimazaki J
J Ocul Pharmacol Ther; 2019; 35(6):350-358. PubMed ID: 31259647
[No Abstract] [Full Text] [Related]
20. Autologous serum eyedrops in the treatment of aniridic keratopathy.
López-García JS; Rivas L; García-Lozano I; Murube J
Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
